Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia
Kimmo Porkka(Helsinki University Hospital), Francis Y. F. Lee(Bristol-Myers Squibb (United States))
Cited by 440
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
|Blood|2019|161
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
|Science Advances|2019|126